Pathstone Holdings’s Lumexa Imaging Holdings LMRI Stock Holding History

Pathstone Holdings’s Portfolio LMRI Stock Details LMRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$193K	Buy	+18,782	New	+$214K	﹤0.01%	2298

Other funds holding LMRI

Massachusetts Financial Services Boston, Massachusetts $296B AUM 23.14% 1-Year Est. Return

Brooklands Fund Management London, United Kingdom $782M AUM 0.49% 1-Year Est. Return

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Royce & Associates New York $11B AUM 39.4% 1-Year Est. Return

Brigade Capital Management New York $1.26B AUM 194.27% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

First Eagle Investment Management New York $63.7B AUM 20.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Pathstone Holdings's LMRI Position: Q3 2026 in Review

Pathstone Holdings opened a new position in Lumexa Imaging Holdings (LMRI) in Q3 2026: 18,782 shares worth $193K. The stake represents ﹤0.01% of the portfolio and ranks #2298 among its holdings.

70 funds tracked by Wall St. Rank hold LMRI as of Q3 2026.

Pathstone Holdings held 18,782 shares of Lumexa Imaging Holdings worth $193K as of Q3 2026.
Lumexa Imaging Holdings was a new Pathstone Holdings position in Q3 2026.
Lumexa Imaging Holdings made up ﹤0.01% of Pathstone Holdings's portfolio in Q3 2026, its #2298 holding.
70 funds tracked by Wall St. Rank held Lumexa Imaging Holdings as of Q3 2026.

Based on Pathstone Holdings's 13F filing for Q3 2026, filed 13 Nov 2026.